Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Isami Mizushima"'
Autor:
Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizushima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1618-1623 (2023)
Abstract Objective Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs) for pulmonary sarcomatoid carcinoma. This multicenter observational study was conducted to evaluate the efficacy of systemic ICI therapy and chemo
Externí odkaz:
https://doaj.org/article/d017de19d4e6443389f1d93a76555a9a
Autor:
Minehiko Inomata, Masahiro Matsumoto, Isami Mizushima, Kana Hayashi, Zenta Seto, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
The Egyptian Journal of Bronchology, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Purpose We conducted a retrospective analysis of the data of patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to investigate the associations between clinical factors and the overall survival. M
Externí odkaz:
https://doaj.org/article/8f2fac69bfef4d0bbfcfa51ee111cb99
Autor:
Takeshi Tsuda, Kensuke Suzuki, Minehiko Inomata, Kana Hayashi, Isami Mizushima, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Yasuaki Masaki, Hirokazu Taniguchi, Kazuyuki Tobe
Publikováno v:
Molecular and Clinical Oncology. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559dc9014f060f66b63c9f1bfbd2b304
https://doi.org/10.3892/mco.2023.2634
https://doi.org/10.3892/mco.2023.2634
Autor:
Shoko Matsui, Kotaro Tokui, Kazuyuki Tobe, Toshiro Miwa, Chihiro Taka, Naoki Takata, Kenji Azechi, Shingo Imanishi, Seisuke Okazawa, Kana Hayashi, Satoshi Nomura, Ryuji Hayashi, Isami Mizushima, Minehiko Inomata, Kenta Kambara
Publikováno v:
In Vivo
Aim We report, herein, three cases of pleomorphic carcinoma of the lung treated with immune checkpoint inhibitors. Case 1: A 73-year-old man was diagnosed as having pleomorphic carcinoma of the lung and treated with pembrolizumab alone. However, he s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006bb4bb204aa43a3e8b22ee437e2fd3
https://doi.org/10.21873/invivo.12428
https://doi.org/10.21873/invivo.12428
Autor:
MINEHIKO INOMATA, MASAHIRO MATSUMOTO, ISAMI MIZUSHIMA, ZENTA SETO, KANA HAYASHI, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI, KAZUYUKI TOBE
Publikováno v:
Cancer Diagn Progn
Background/Aim: The association between tumor PD-L1 expression and the rate of acquisition of the T790M mutation during treatment with first-/second-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is a matter of stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef7fc1cb0c5dbce50a80c54e706eb8f8
https://europepmc.org/articles/PMC9066543/
https://europepmc.org/articles/PMC9066543/
Autor:
Kenta Kambara, Minehiko Inomata, Seisuke Okazawa, Shingo Imanishi, Kotaro Tokui, Isami Mizushima, Chihiro Taka, Kana Hayashi, Toshiro Miwa, Masahiro Matsumoto, Kazuyuki Tobe, Ryuji Hayashi, Shoko Matsui, Zenta Seto
Purpose We conducted a retrospective analysis of the data of patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) to investigate the associations between clinical factors and the overall survival. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee5e8e8c2edcda8b8421656bbe8244a
https://doi.org/10.21203/rs.3.rs-747775/v1
https://doi.org/10.21203/rs.3.rs-747775/v1
Autor:
Kotaro Tokui, Isami Mizushima, Kazuyuki Tobe, Seisuke Okazawa, Ryuji Hayashi, Toshiro Miwa, Kana Hayashi, Shingo Imanishi, Kenji Azechi, Chihiro Taka, Naoki Takata, Shoko Matsui, Kenta Kambara, Minehiko Inomata
Publikováno v:
Cancer Diagn Progn
Background/Aim: We conducted a retrospective analysis of the survival durations of 25 patients diagnosed as having non-squamous cell non-small cell lung cancer with negative or low tumor programmed death-ligand 1 (PD-L1) expression treated with immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0142c84b971dec7bf13e2b803d67cee6
https://pubmed.ncbi.nlm.nih.gov/35399317
https://pubmed.ncbi.nlm.nih.gov/35399317
Autor:
KANA HAYASHI, KOTARO TOKUI, MINEHIKO INOMATA, KENJI AZECHI, ISAMI MIZUSHIMA, NAOKI TAKATA, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI, SATOSHI NOMURA, KAZUYUKI TOBE
Publikováno v:
In Vivo; May/Jun2021, Vol. 35 Issue 3, p1687-1692, 6p